Cytovale logo

Cytovale

At Cytovale, we’re focused on more rapid and insightful ways to diagnose fast-moving and immune-mediated diseases.

121 employees · est. 2013 · South San Francisco, United...

VS
GeneMedicine logo

GeneMedicine

Biopharmaceutical company focusing on R&D and commercializing its oncolytic adenovirus platform for cancer treatment.

11 employees · est. 2014 · Seoul, Korea South

Cytovale is the older company (2013 vs 2014); Cytovale is the larger of the two.

Side-by-Side Comparison

Cytovale GeneMedicine
Founded
2013 older 2014
Headquarters
South San Francisco, United States Seoul, Korea South
Employees
121 larger 11
Industry
AI, Health Care, Life Sciences Not tracked yet
Funding Stage
Series C Series A
Total Funding
$128.59M $15.00M
Funding Rounds
9 1
Services
Not tracked yet Gene Therapy Development, Research and Development, Contract Development and Manufacturing, Platform Technology Solutions, Biomedical Research
Target Customers
Not tracked yet Pharmaceutical Companies, Biotechnology Firms, Healthcare Providers, Research Institutions, Patients with Chronic Illnesses
Taxonomy
Medical Diagnostics, Cell Mechanics, Sepsis Diagnosis, Immune-mediated Diseases, Early Detection Technologies, Biomechanical Evaluation, FDA Cleared, Rapid Diagnostics, San Francisco-based Company, Immune Response, Critical Care, Sepsis Mortality Oncolytic Virotherapy, Adenovirus Platform, Viral Immunotherapy, Cancer Therapeutics, Gene And Cell Therapy, Intratumoral Administration, Systemic Delivery Platform, Tumor-Targeted Therapies, Immunogenic Cell Death, Immune Checkpoint Inhibitors, Advanced Cancer Treatment, Antitumor Immune Activation, Biomedical Engineering, Genetic Engineering, Synergistic Combination Therapy
Website
cytovale.com gene-medicine.com
Cytovale logo

About Cytovale

Cytovale: Cytovale, a medical diagnostics company founded in 2013, is focused on providing a more rapid and insightful way to diagnose fast-moving and immune-mediated diseases. Their FDA cleared IntelliSep test pioneers a new way of quickly and accurately analyzing white blood cells to stratify a pa...

GeneMedicine logo

About GeneMedicine

GeneMedicine is a biopharmaceutical company established in 2014 and headquartered in Korea South, positioned at the forefront of viral immunotherapy for cancer treatment. Specializing in R&D and commercialization of an advanced oncolytic adenovirus platform, the startup is creating groundbreaking th...

Be first to know when either one moves

Funding rounds, hiring surges, leadership changes and stack switches at Cytovale and GeneMedicine — tracked continuously, sent the day they land.

Watch both — free

Funding, hiring, leadership and stack changes at Cytovale and GeneMedicine — by email.

Frequently Asked Questions

Cytovale — At Cytovale, we’re focused on more rapid and insightful ways to diagnose fast-moving and immune-mediated diseases. . GeneMedicine — Biopharmaceutical company focusing on R&D and commercializing its oncolytic adenovirus platform for cancer treatment.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Cytovale has raised $128.59M while GeneMedicine has raised $15.00M.
Cytovale and GeneMedicine operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Cytovale with someone else

Start typing a company name or domain.

One analytics cookie (Google Analytics). Cookie Policy